Bio Venture Partners Ltd. Arkin serves as Executive at Keros Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Bio Venture Partners Ltd. Arkin has executed 4 insider transactions totaling $1.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 13, 2020 involved exercising options for 1,382,295 shares valued at $0.
Bio Venture Partners Ltd. Arkin currently holds 1,382,295 shares of Keros Therapeutics, Inc. (KROS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bio Venture Partners Ltd. Arkin has been a net buyer of KROS stock. They have purchased $1.9M and sold $0 worth of shares.
Bio Venture Partners Ltd. Arkin's most recent insider trade was on Apr 13, 2020, when they sold 1,382,295 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $16.00 |
| Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 343,270 | $N/A | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 167,537 | $N/A | Discretionary |